Carver Biosciences

Carver Biosciences is a gene therapy company located in Boston, Massachusetts, developing CRISPR-based treatments for RNA viruses that infect humans. Carver's approach is a programmable platform technology that can provide a universal solution for treating many viruses, as targeting is determined by guide RNA sequences. The company’s foundational technology was developed by co-founder Dr. Cameron Myhrvold.